11457 related articles for article (PubMed ID: 14562175)
1. Macrophages and microcirculation in regressed and partially regressed irradiated choroidal and ciliary body melanomas.
Toivonen P; Mäkitie T; Kujala E; Kivelä T
Curr Eye Res; 2003 Oct; 27(4):237-45. PubMed ID: 14562175
[TBL] [Abstract][Full Text] [Related]
2. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
[TBL] [Abstract][Full Text] [Related]
3. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases.
Toivonen P; Mäkitie T; Kujala E; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):1-6. PubMed ID: 14691146
[TBL] [Abstract][Full Text] [Related]
4. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
6. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
[TBL] [Abstract][Full Text] [Related]
7. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas.
Folberg R; Chen X; Boldt HC; Pe'er J; Brown CK; Woolson RF; Maniotis AJ
Ophthalmology; 2001 May; 108(5):996-1001. PubMed ID: 11320035
[TBL] [Abstract][Full Text] [Related]
8. The effect of pre-enucleation radiotherapy on mitotic activity of choroidal and ciliary body melanomas.
Augsburger JJ; Eagle RC; Chiu M; Shields JA
Ophthalmology; 1987 Dec; 94(12):1627-30. PubMed ID: 3431833
[TBL] [Abstract][Full Text] [Related]
9. Analysis of inflammatory cells in uveal melanoma after prior irradiation.
Vu TH; Bronkhorst IH; Versluis M; Marinkovic M; van Duinen SG; Vrolijk J; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):360-9. PubMed ID: 23211827
[TBL] [Abstract][Full Text] [Related]
10. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study.
Rummelt V; Folberg R; Rummelt C; Gruman LM; Hwang T; Woolson RF; Yi H; Naumann GO
Ophthalmology; 1994 Apr; 101(4):718-27. PubMed ID: 8152768
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar size in choroidal and ciliary body melanomas and corresponding hepatic metastases.
Al-Jamal RT; Toivonen P; Kivelä T
Acta Ophthalmol; 2010 Jun; 88(4):458-62. PubMed ID: 19549104
[TBL] [Abstract][Full Text] [Related]
12. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
13. The microcirculation of choroidal and ciliary body melanomas.
Folberg R; Mehaffey M; Gardner LM; Meyer M; Rummelt V; Pe'er J
Eye (Lond); 1997; 11 ( Pt 2)():227-38. PubMed ID: 9349418
[TBL] [Abstract][Full Text] [Related]
14. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
Seregard S; Lundell G; Lax I; af Trampe E; Kock E
Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
[TBL] [Abstract][Full Text] [Related]
15. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
Al-Jamal RT; Kivelä T
Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
[TBL] [Abstract][Full Text] [Related]
16. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body.
Al-Jamal RT; Mäkitie T; Kivelä T
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2381-9. PubMed ID: 12766034
[TBL] [Abstract][Full Text] [Related]
17. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
[TBL] [Abstract][Full Text] [Related]
18. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the tumor regression rate of 127 uveal melanomas irradiated with 106 Ru/106 Rh. Attempted analysis of the correlations between per-operative cytology and histopathology of the enucleated eye and the tumoral regression on the one hand, and general prognosis on the other hand].
Grange JD; Thacoor S; Bievelez B; Jean-Louis B; Baute B; Gérard JP; Sentenac I; Fontanière B; Bailly C
Ophtalmologie; 1990; 4(3):221-4. PubMed ID: 2250951
[TBL] [Abstract][Full Text] [Related]
20. Episcleral plaque radiotherapy for uveal melanoma.
Giblin ME; Shields JA; Augsburger JJ; Brady LW
Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
